| Analysis | Metabolite Name | Measured Value | Units | Treatment |
|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 4782 | Peak area | DEHP |
| Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 16511 | Peak area | Control |
| Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 29768 | Peak area | DEHP |
| Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 29856 | Peak area | Control |
| Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 32845 | Peak area | Control |
| Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 92143 | Peak area | DEHP |
| Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | Peak area | Control | |
| Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | Peak area | DEHP | |
| Reversed phase POSITIVE ION MODE | GLUTAMINE (M+NA)+ | 5463 | Peak area | DEHP |
| Reversed phase POSITIVE ION MODE | GLUTAMINE (M+NA)+ | Peak area | Control | |
| Reversed phase POSITIVE ION MODE | GLUTAMINE (M+NA)+ | Peak area | DEHP |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|